In these samples, a concomitant mutation in HRAS gene (p.Gly12Asp) was identified, confirming the association between inactivating BRAF mutations and the stimulation of the Raf-MEK-ERK pathway by other effectors, as a mutated RAS protein, in a molecular subtype of melanomas. Here, HRAS is linked to melanoma.